(Q38126386)

29 August 2017

Hypoglycemia in patients with type 1 diabetes: epidemiology, pathogenesis, and prevention (English)

1 reference

29 August 2017

0 references

0 references

1 reference

3

Samuel Dagogo-Jack

1 reference

29 August 2017

Omodele Awoniyi

1

1 reference

29 August 2017

Rabia Rehman

series ordinal

2

1 reference

29 August 2017

language of work or name

1 reference

1 October 2013

1 reference

29 August 2017

Current diabetes report

1 reference

29 August 2017

13

1 reference

29 August 2017

5

1 reference

29 August 2017

669-678

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-013-0411-y

29 August 2017

0 references

cites work

Diabetes control and complications

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Hypoglycemia in type 1 diabetes mellitus: pathophysiology and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Reducing rates of severe hypoglycemia in a population-based cohort of children and adolescents with type 1 diabetes over the decade 2000-2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

The barrier of hypoglycemia in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Hypoglycemia in type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Symptoms of hypoglycaemia in people with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Hypoglycemia risk reduction in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

The impact of a decade of changing treatment on rates of severe hypoglycemia in a population-based cohort of children with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Time trends in mortality in patients with type 1 diabetes: nationwide population based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Long-term mortality in nationwide cohorts of childhood-onset type 1 diabetes in Japan and Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

The importance of hypoglycemia in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Severe hypoglycemia is a serious complication and becoming an economic burden in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Trends and disparities in U.S. emergency department visits for hypoglycemia, 1993-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Emergency hospitalizations for adverse drug events in older Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Morbidity of hypoglycemia in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes--the 'dead in bed' syndrome revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Proinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Repeated episodes of hypoglycemia as a potential aggravating factor for preclinical atherosclerosis in subjects with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Vascular disease and diabetes: is hypoglycaemia an aggravating factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

The science of hypoglycemia in patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Hypoglycemia: an overview of fear of hypoglycemia, quality-of-life, and impact on costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Hypoglycemia preceding fatal car collisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

The impact of non-severe hypoglycemic events on work productivity and diabetes management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

The selective control of glycolysis, gluconeogenesis and glycogenesis by temporal insulin patterns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Insulin regulates adipocyte lipolysis via an Akt-independent signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

The metabolic actions of glucagon revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Induction of ketogenesis and fatty acid oxidation by glucagon and cyclic AMP in cultured hepatocytes from rabbit fetuses. Evidence for a decreased sensitivity of carnitine palmitoyltransferase I to malonyl-CoA inhibition after glucagon or cyclic AMP

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Hypoglycemia in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Loss of the decrement in intraislet insulin plausibly explains loss of the glucagon response to hypoglycemia in insulin-deficient diabetes: documentation of the intraislet insulin hypothesis in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Hypoglycemia in diabetes: pathophysiological mechanisms and diurnal variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Hypoglycemia unawareness in IDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Hypoglycemia and the sympathoadrenal system: neurogenic symptoms are largely the result of sympathetic neural, rather than adrenomedullary, activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Mechanisms of sympathoadrenal failure and hypoglycemia in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Defective counterregulation and hypoglycemia unawareness in diabetes: mechanisms and emerging treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Limited impact of vigorous exercise on defenses against hypoglycemia: relevance to hypoglycemia-associated autonomic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Role of cortisol in the pathogenesis of deficient counterregulation after antecedent hypoglycemia in normal humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Role of corticotrophin-releasing hormone in the impairment of counterregulatory responses to hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Cortisol elevations comparable to those that occur during hypoglycemia do not cause hypoglycemia-associated autonomic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Blood-to-brain glucose transport, cerebral glucose metabolism, and cerebral blood flow are not increased after hypoglycemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Adaptation in brain glucose uptake following recurrent hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Ventromedial hypothalamic glucokinase is an important mediator of the counterregulatory response to insulin-induced hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Potential role for AMP-activated protein kinase in hypoglycemia sensing in the ventromedial hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Increased GABAergic output in the ventromedial hypothalamus contributes to impaired hypoglycemic counterregulation in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Portal vein hypoglycemia is essential for full induction of hypoglycemia-associated autonomic failure with slow-onset hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Attenuation of counterregulatory responses to recurrent hypoglycemia by active thalamic inhibition: a mechanism for hypoglycemia-associated autonomic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Modulation of β-adrenergic receptors in the ventromedial hypothalamus influences counterregulatory responses to hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Recent advances in the prevention of hypoglycemia in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Preventing hypoglycaemia: what is the appropriate glucose alert value?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Standards of medical care in diabetes--2013

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Continuous glucose monitoring and intensive treatment of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Nocturnal hypoglycemia detected with the Continuous Glucose Monitoring System in pediatric patients with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

The effect of continuous glucose monitoring in well-controlled type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Prediction of severe hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Blood glucose awareness training (BGAT-2): long-term benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Hypoglycemia anticipation, awareness and treatment training (HAATT) reduces occurrence of severe hypoglycemia among adults with type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

21 January 2018

Exercise and diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Hypoglycaemia with insulin aspart: a double-blind, randomised, crossover trial in subjects with Type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Restored hypoglycemic counterregulation is stable in successful pancreas transplant recipients for up to 19 years after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Restoration of hypoglycemia awareness after islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

International trial of the Edmonton protocol for islet transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Transplantation for the treatment of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

The relationship between ACE genotype and risk of severe hypoglycaemia in a large population-based cohort of children and adolescents with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0411-Y

Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications

21 January 2018

1 reference

12 December 2020

Prediction of Severe Hypoglycaemia by Angiotensin-Converting Enzyme Activity and Genotype in Type 1 Diabetes

1 reference

12 December 2020

Banting Lecture. Hypoglycemia: the limiting factor in the management of IDDM.

1 reference

12 December 2020

Hypoglycemia, diabetes, and cardiovascular disease

1 reference

12 December 2020

Multifactorial origin of hypoglycemic symptom unawareness in IDDM. Association with defective glucose counterregulation and better glycemic control

1 reference

12 December 2020

Transplantation for the treatment of type 1 diabetes

1 reference

12 December 2020

Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group

1 reference

12 December 2020

Hypoglycemia-associated autonomic failure in diabetes

1 reference

12 December 2020

Contribution of hypoglycemia to medical care expenditures and short-term disability in employees with diabetes

1 reference

12 December 2020

Episodes of severe hypoglycemia in type 1 diabetes are preceded and followed within 48 hours by measurable disturbances in blood glucose

1 reference

12 December 2020

Driving mishaps and hypoglycaemia: risk and prevention

1 reference

12 December 2020

Altered ventricular repolarization during hypoglycaemia in patients with diabetes

1 reference

12 December 2020

A randomized, blinded trial of uncooked cornstarch to diminish nocturnal hypoglycemia at diabetes camp

1 reference

12 December 2020

Oral bedtime cornstarch supplementation reduces the risk for nocturnal hypoglycaemia in young children with type 1 diabetes

1 reference

12 December 2020

Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction

1 reference

12 December 2020

Activity of angiotensin-converting enzyme and risk of severe hypoglycaemia in type 1 diabetes mellitus

1 reference

12 December 2020

Hypoglycemia unawareness

1 reference

12 December 2020

Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM

1 reference

12 December 2020

1 reference

12 December 2020

Physical activity/exercise and diabetes mellitus

1 reference

12 December 2020

Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes

1 reference

12 December 2020

Glucose transporter gene expression in rat brain: Pretranslational changes associated with chronic insulin-induced hypoglycemia, fasting, and diabetes.

1 reference

12 December 2020

10.1007/S11892-013-0411-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

29 August 2017

0 references

1 reference